4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-23-033003
Chief Commercial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olinger Margaret Chief Commercial Officer | 2023-07-12 | Option exercise | +20,000 | $0.37 | $7,400 | 251,108 | D |
| Derivatives | |||||||
| Olinger Margaret Chief Commercial Officer | 2023-07-12 | Option exercise · Stock Option (Right to Buy) | −20,000 | 69,577 | D | ||
Loading xslF345X04/ownership.xml…